Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Fargue

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Kidney International|November 27, 2014
Factors influencing clinical outcome in patients with primary hyperoxaluria type 1Sonia Fargue
Clinical Kidney Journal|May 20, 2022
Primary hyperoxaluria type 1: pathophysiology and geneticsSonia Fargue, Cécile Acquaviva Bourdain
Current Opinion in Organ Transplantation|August 25, 2010
Primary hyperoxaluria type 1: strategy for organ transplantationPierre Cochat, Sonia Fargue, Jérôme Harambat
Biochimica Et Biophysica Acta|April 20, 2013
Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1Sonia Fargue, Gill Rumsby, Christopher J Danpure
The Journal of Biological Chemistry|December 12, 2012
Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor alleleSonia Fargue, Jackie Lewin, Gill Rumsby, et al.
International Journal of Nephrology|July 13, 2011
Primary hyperoxaluriaJérôme Harambat, Sonia Fargue, Justine Bacchetta, et al.
Current Opinion in Urology|January 3, 2020
Future treatments for hyperoxaluriaZachary Burns, John Knight, Sonia Fargue, et al.
Pediatric Nephrology (Berlin, Germany)|July 1, 2006
Primary hyperoxaluria type 1: still challenging!Pierre Cochat, Aurélia Liutkus, Sonia Fargue, et al.
Biochimica Et Biophysica Acta|February 9, 2016
Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assaySonia Fargue, John Knight, Ross P Holmes, et al.
Gut Microbes|September 23, 2025
<b>Baseline abundance of oxalate-degrading bacteria determines response to</b> <i><b>Oxalobacter formigenes</b></i> <b>probiotic therapy</b>Mangesh Suryavanshi, Arthur Franklin, Sonia Fargue, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Kidney International|November 27, 2014
Factors influencing clinical outcome in patients with primary hyperoxaluria type 1Sonia Fargue
Clinical Kidney Journal|May 20, 2022
Primary hyperoxaluria type 1: pathophysiology and geneticsSonia Fargue, Cécile Acquaviva Bourdain
Current Opinion in Organ Transplantation|August 25, 2010
Primary hyperoxaluria type 1: strategy for organ transplantationPierre Cochat, Sonia Fargue, Jérôme Harambat
Biochimica Et Biophysica Acta|April 20, 2013
Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1Sonia Fargue, Gill Rumsby, Christopher J Danpure
The Journal of Biological Chemistry|December 12, 2012
Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor alleleSonia Fargue, Jackie Lewin, Gill Rumsby, et al.
International Journal of Nephrology|July 13, 2011
Primary hyperoxaluriaJérôme Harambat, Sonia Fargue, Justine Bacchetta, et al.
Current Opinion in Urology|January 3, 2020
Future treatments for hyperoxaluriaZachary Burns, John Knight, Sonia Fargue, et al.
Pediatric Nephrology (Berlin, Germany)|July 1, 2006
Primary hyperoxaluria type 1: still challenging!Pierre Cochat, Aurélia Liutkus, Sonia Fargue, et al.
Biochimica Et Biophysica Acta|February 9, 2016
Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assaySonia Fargue, John Knight, Ross P Holmes, et al.
Gut Microbes|September 23, 2025
<b>Baseline abundance of oxalate-degrading bacteria determines response to</b> <i><b>Oxalobacter formigenes</b></i> <b>probiotic therapy</b>Mangesh Suryavanshi, Arthur Franklin, Sonia Fargue, et al.
Pageof 4